The Center for Duchenne Muscular Dystrophy ('CDMD') Core Center provides an academic home to researchers in the Los Angeles area interested in discovery and translafion of therapies in the muscular dystrophies. The Center facilitates innovafion and provides institufional resources for interdisciplinary,. translafional research, by providing its 45 members access to unique core facilities, pilot funding mechanisms, seminars and an annual retreat focused on muscle research. This is an excifing fime in muscular dystrophy research, since for the first fime, several rafionally designed therapeufics are in clinical trials and novel therapeufic pathways have been identified. In this era of translation, the CDMD Core Center is well posifioned to capitalize on the progress that has been made, to identify drugs in novel dystrophyrelevant pathways and bring these drugs to clinical trials. The Administrative and Enrichment core will help to speed progress along these lines by promofing collaborafion and communicafion amongst Center Scientists, managing the Pilot and Feasibility Seed Grant Program, organizing seminars, retreats and group meefings. Aside from the scienfific acfivifies, the Center has strong missions in educafion, clinical care and outreach. The Administrative and Enrichment Core has 6 main goals;
aim 1 : to facilitate communication between Center Scienfists, by providing administrative and website support to the Cores and all acfivifies ofthe Center;
aim 2 : to facilitate collaborafion between Center Scienfists by organizing enrichment acfivifies such as a seminar series, annual retreat and regular working group meefings;
aim 3 : to facilitate collaborafion between CDMD basic scienfists and clinicians in the neuromuscular clinic and to improve clinical care for those suffering with neuromuscular disorders;
aim 4 : to oversee the review and funding ofthe Pilot and Feasibility Seed Grant Program;
aim 5 : to improve the training experience of individuals seeking to develop knowledge and skills in translafional research relevant to muscular dystrophy, by promofing acfivifies that benefit the educafion mission ofthe CDMD;
aim 6 : to engage the community through outreach efforts, by improving disseminafion of informafion about the muscular dystrophies and CDMD events relevant to the public.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
2P30AR057230-06
Application #
8708698
Study Section
Special Emphasis Panel (ZAR1-XZ (M1))
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$315,700
Indirect Cost
$110,700
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
DiFranco, Marino; Kramerova, Irina; Vergara, Julio L et al. (2016) Attenuated Ca(2+) release in a mouse model of limb girdle muscular dystrophy 2A. Skelet Muscle 6:11
Reyhan, Meral L; Wang, Zhe; Kim, Hyun J et al. (2016) Effect of free-breathing on left ventricular rotational mechanics in healthy subjects and patients with duchenne muscular dystrophy. Magn Reson Med :
Capote, Joana; Kramerova, Irina; Martinez, Leonel et al. (2016) Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype. J Cell Biol 213:275-88
Srinivasan, Subashini; Kroeker, Randall M; Gabriel, Simon et al. (2016) Free-breathing variable flip angle balanced SSFP cardiac cine imaging with reduced SAR at 3T. Magn Reson Med 76:1210-6
Brown, Robert; Lee, Hane; Eskin, Ascia et al. (2016) Leveraging ancestry to improve causal variant identification in exome sequencing for monogenic disorders. Eur J Hum Genet 24:113-9
Young, Courtney S; Hicks, Michael R; Ermolova, Natalia V et al. (2016) A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells. Cell Stem Cell 18:533-40
Kramerova, Irina; Ermolova, Natalia; Eskin, Ascia et al. (2016) Failure to up-regulate transcription of genes necessary for muscle adaptation underlies limb girdle muscular dystrophy 2A (calpainopathy). Hum Mol Genet 25:2194-2207
Gibbs, Elizabeth M; Marshall, Jamie L; Ma, Eva et al. (2016) High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD. Hum Mol Genet :
Mokhonova, Ekaterina I; Avliyakulov, Nuraly K; Kramerova, Irina et al. (2015) The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2. Hum Mol Genet 24:2873-83
Arboleda, Valerie A; Lee, Hane; Dorrani, Naghmeh et al. (2015) De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Hum Genet 96:498-506

Showing the most recent 10 out of 48 publications